Potential mechanisms of active components from traditional Chinese medicine in acute myeloid leukemia via ferroptosis: an integrative bioinformatics and molecular modeling study

Background Acute myeloid leukemia (AML) represents a heterogeneous hematologic malignancy with divergent clinical outcomes. The prognostic significance of ferroptosis-associated genes and bioactive compounds derived from traditional Chinese medicine (TCM) in AML has not been fully characterized. We sought to construct an AML prognostic model by integrating ferroptosis-related genes with TCM molecular targets and to investigate the mechanistic basis underlying their interactions. Methods Transcriptomic data were obtained from TCGA-LAML, GSE114868 (training cohorts) and GSE71014 (validation cohort). Candidate genes were screened by overlapping differentially expressed genes, ferroptosis-related gene sets and TCM target databases. Analyses included prognostic gene selection, model construction and validation, nomogram establishment, immune microenvironment profiling, gene set enrichment analysis (GSEA), Mendelian randomization (MR), molecular docking and molecular dynamics (MD) simulations. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was used to validate gene expression. Results CDKN1A and HMOX1 were identified as key prognostic genes, and the model showed stable predictive performance. Risk scores were correlated with age, and both genes independently predicted AML prognosis. The high-risk group had an immunosuppressive microenvironment. The two genes were enriched in ferroptosis pathways. MR analysis suggested a potential causal association between CDKN1A and AML (IVW P = 0.0104), whereas HMOX1 did not reach statistical significance (IVW P = 0.109). Quercetin and luteolin showed potential binding to the target proteins. RT-qPCR suggested lower CDKN1A and HMOX1 expression in a small AML cohort; these findings require validation in larger cohorts. Conclusion The CDKN1A and HMOX1 -based prognostic model showed potential for stratifying AML patients in exploratory analyses. TCM bioactive components may target these genes and regulate ferroptosis pathways, but these mechanisms remain hypothetical and require experimental validation.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-12
DOI
https://doi.org/10.3389/fonc.2026.2000304
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Potential mechanisms of active components from traditional Chinese medicine in acute myeloid leukemia via ferroptosis: an integrative bioinformatics and molecular modeling study

Yining Chen, Baozhen Xie, Bin Liao, Yan Qi et al.
Frontiers in Oncology
Ferroptosis and cancer prognosis
article

Potential mechanisms of active components from traditional Chinese medicine in acute myeloid leukemia via ferroptosis: an integrative bioinformatics and molecular modeling study

Yining Chen, Baozhen Xie, Bin Liao, Yan Qi, Xiangfan Chen
article en

Abstract

Background Acute myeloid leukemia (AML) represents a heterogeneous hematologic malignancy with divergent clinical outcomes. The prognostic significance of ferroptosis-associated genes and bioactive compounds derived from traditional Chinese medicine (TCM) in AML has not been fully characterized. We sought to construct an AML prognostic model by integrating ferroptosis-related genes with TCM molecular targets and to investigate the mechanistic basis underlying their interactions. Methods Transcriptomic data were obtained from TCGA-LAML, GSE114868 (training cohorts) and GSE71014 (validation cohort). Candidate genes were screened by overlapping differentially expressed genes, ferroptosis-related gene sets and TCM target databases. Analyses included prognostic gene selection, model construction and validation, nomogram establishment, immune microenvironment profiling, gene set enrichment analysis (GSEA), Mendelian randomization (MR), molecular docking and molecular dynamics (MD) simulations. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was used to validate gene expression. Results CDKN1A and HMOX1 were identified as key prognostic genes, and the model showed stable predictive performance. Risk scores were correlated with age, and both genes independently predicted AML prognosis. The high-risk group had an immunosuppressive microenvironment. The two genes were enriched in ferroptosis pathways. MR analysis suggested a potential causal association between CDKN1A and AML (IVW P = 0.0104), whereas HMOX1 did not reach statistical significance (IVW P = 0.109). Quercetin and luteolin showed potential binding to the target proteins. RT-qPCR suggested lower CDKN1A and HMOX1 expression in a small AML cohort; these findings require validation in larger cohorts. Conclusion The CDKN1A and HMOX1 -based prognostic model showed potential for stratifying AML patients in exploratory analyses. TCM bioactive components may target these genes and regulate ferroptosis pathways, but these mechanisms remain hypothetical and require experimental validation.

Frontiers in OncologyVol. 16
Fujian University of Traditional Chinese Medicine (CN)
Fujian University of Traditional Chinese Medicine, Fujian Provincial Health Commission
Good health and well-being
Ferroptosis and cancer prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon